LucidQuest’s Post

Thoughts on this? >> US bankrolls a third of global Pandemic Fund. Can it get congressional support? >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #healthcare #biotech #productmarketing

One of the most common questions we've heard over the last year is how the IRA will impact portfolio value. In this article, Rachel Fong, Tonny Huang, and I break down the provisions that will have the biggest impact, both good and bad. Check out the article below to learn more: https://lnkd.in/g7bby9wg

#PortfolioValue of Biopharma companies is under pressure from price regulation. What impact does the US #InflationReductionAct have on asset values? Read our perspective!

The Inflation Reduction Act is having profound effect on the US economy including in the biopharma sector. My colleagues Betty Pio, Tonny Huang and Rachel Fong explore how we should think about valuing pharmaceutical assets in the context of new economic models. #kearney #pharmaceutical #lifesciencesindustry

On what basis are they raising price and by how much?

Update: See the new video link in the comments. Don't miss this news story reminder why the fight to secure the US Drug Supply Chain never ends. Key requirements of DSCSA to help prevent: - Authorized Trading Partner checks using state and/or federal license and registrations - Lot Level moving to Saleable Unit level Transaction Data - Transaction Statement showing the seller has confirmed following DSCSA - Ability to request or respond to product verification or product tracing requests - FDA Form 3911 filing and/or alerting to trading partners where required in the case of suspect/illegetimate product - Familarity with related FDA guidance and all DSCA requirements #DSCSA Fraud in a bottle: Big Pharma takes on counterfeit drugs (https://lnkd.in/gdsPB3KD)

Unlocking the Power of Value-Based Pricing 💡 In this research, we look at a real-life example of how a value-based model can support market success using GPI’s horizon methodology, and the impact on the price potential of the asset following an increase in its asset value. Read more: https://lnkd.in/eZ4HDxqW #PricingStrategy #MarketAccess #ValueBasedPricing

VC investment in biopharma is on the rise in the US, with Q2 2024 showing significant growth over Q1 and the previous year, according to Evaluate Pharma. Great insights by Mandy Jackson! #Biopharma #VentureCapital #InvestmentTrends

Market mood swings! Do investors overreact to USFDA actions? Let’s separate the hype from the reality. Read @HimadriBuch and @VikasReports’s insights to understand the real impact on a company’s financials. https://bit.ly/3y0JxWq

Public companies and investment advisers should be on alert and reevaluate their insider trading policies after the SEC won a jury verdict in its first "shadow trading" insider trading action. A cross practice team breaks down what public entities should consider in their latest client alert. https://ow.ly/iraL50Rhhl4